US 12370181
Regimens of estrogen receptor antagonists
granted A61KA61K31/137A61K31/138
Quick answer
US patent 12370181 (Regimens of estrogen receptor antagonists) held by Olema Pharmaceuticals, Inc. expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Olema Pharmaceuticals, Inc.
- Grant date
- Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/137, A61K31/138, A61K31/436, A61K31/437